Bapineuzumab (APP Abeta) - Research Grade Biosimilar
Product Specifications
Background
Bapineuzumab has been investigated for the treatment of Alzheimer's Disease.
Immunogen
Humanized / APP Abeta [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Neuroscience
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Fragment
IgG1-nd
NCBI Organism
Homo sapiens
Other Product Names
AAB-001
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680257-100 1x 100 µL
Cytokeratin, HMW (AE-3), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040017-500 1x 500 µL
Ep-CAM / CD326 (VU-1D9), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041960-100 1x 100 µL
GAD2 / GAD65 (GABAergic Neuronal Marker) (GAD2/1960), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740693-500 1x 500 µL
CD56 / NCAM (123C3.D5 + 123A8), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741888-100 1x 100 µL
CD1a / HTA1 (Mature Langerhans Cells Marker) (rC1A/711), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details